EdgarLookup

Centuri Holdings, Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Centuri Holdings, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
0.8%
Profit Margin
Net income ÷ revenue
0.9%
Return on Assets
Net income ÷ assets
1.75x
Debt-to-Equity
Total liabilities ÷ equity
+13.1%
Revenue Growth
Year over year

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Dec 28, 2025 $2.98B Feb 26, 2026
FY2025 Dec 29, 2024 $2.64B Feb 26, 2026
FY2025 Dec 31, 2023 $2.90B Feb 26, 2026
FY2024 Jan 1, 2023 $2.76B Feb 26, 2025

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2025 Dec 28, 2025 $246.57M Feb 26, 2026
FY2025 Dec 29, 2024 $220.67M Feb 26, 2026
FY2025 Dec 31, 2023 $273.44M Feb 26, 2026
FY2024 Jan 1, 2023 $214.61M Feb 26, 2025

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 28, 2025 $22.40M Feb 26, 2026
FY2025 Dec 29, 2024 ($6.72M) Feb 26, 2026
FY2025 Dec 31, 2023 ($186.18M) Feb 26, 2026
FY2024 Jan 1, 2023 ($168.15M) Feb 26, 2025

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 28, 2025 $92.82M Feb 26, 2026
FY2025 Dec 29, 2024 $86.78M Feb 26, 2026
FY2025 Dec 31, 2023 ($77.56M) Feb 26, 2026
FY2024 Jan 1, 2023 ($101.43M) Feb 26, 2025

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Dec 28, 2025 $126.46M Feb 26, 2026
FY2025 Dec 29, 2024 $107.25M Feb 26, 2026
FY2025 Dec 31, 2023 $110.34M Feb 26, 2026
FY2024 Jan 1, 2023 $109.20M Feb 26, 2025

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 28, 2025 $78.12M Feb 26, 2026
FY2025 Dec 29, 2024 $158.23M Feb 26, 2026
FY2025 Dec 31, 2023 $167.47M Feb 26, 2026
FY2024 Jan 1, 2023 $94.63M Feb 26, 2025

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 28, 2025 $86.33M Feb 26, 2026
FY2025 Dec 29, 2024 $99.33M Feb 26, 2026
FY2025 Dec 31, 2023 $106.65M Feb 26, 2026
FY2024 Jan 1, 2023 $129.59M Feb 26, 2025

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 28, 2025 $2.41B Feb 26, 2026
FY2025 Dec 29, 2024 $2.07B Feb 26, 2026
FY2024 Dec 31, 2023 $2.19B Feb 26, 2025

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 28, 2025 $1.53B Feb 26, 2026
FY2025 Dec 29, 2024 $1.51B Feb 26, 2026
FY2024 Dec 31, 2023 $1.86B Feb 26, 2025

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 28, 2025 $872.97M Feb 26, 2026
FY2025 Dec 29, 2024 $555.55M Feb 26, 2026
FY2025 Dec 31, 2023 $225.99M Feb 26, 2026
FY2025 Jan 1, 2023 $386.75M Feb 26, 2026
FY2024 Jan 2, 2022 $479.61M Feb 26, 2025

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 28, 2025 $395.67M Feb 26, 2026
FY2025 Dec 29, 2024 $368.30M Feb 26, 2026
FY2025 Dec 31, 2023 $375.89M Feb 26, 2026
FY2024 Jan 1, 2023 $587.68M Feb 26, 2025

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 28, 2025 ($128.41M) Feb 26, 2026
FY2025 Dec 29, 2024 ($150.72M) Feb 26, 2026
FY2024 Dec 31, 2023 ($144.11M) Feb 26, 2025

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 28, 2025 $126.63M Feb 26, 2026
FY2025 Dec 29, 2024 $49.02M Feb 26, 2026
FY2025 Dec 31, 2023 $33.41M Feb 26, 2026

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 28, 2025 0 Feb 26, 2026
FY2025 Dec 29, 2024 0 Feb 26, 2026
FY2025 Dec 31, 2023 (2) Feb 26, 2026
FY2024 Jan 1, 2023 (2) Feb 26, 2025

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 28, 2025 0 Feb 26, 2026
FY2025 Dec 29, 2024 0 Feb 26, 2026
FY2025 Dec 31, 2023 (2) Feb 26, 2026
FY2024 Jan 1, 2023 (2) Feb 26, 2025

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 28, 2025 100.72M Feb 26, 2026
FY2025 Dec 29, 2024 88.52M Feb 26, 2026
FY2024 Dec 31, 2023 1,000 Feb 26, 2025